亿都(国际控股)(00259)盘中涨超10%，截至发稿，涨8.33%，报4.03港元，成交额522.62万港元。 此外，亿都(国际控股)近期公布9月底中期业绩，收入约5.54亿港元，同比增长5.13%；公司拥有人应占 溢利约12.18亿港元，同比增长约11.55倍。溢利增加主要是由于按公允值计入损益的财务资产公允值变 动的收益所致。 消息面上，沐曦股份发布首次公开发行股票并在科创板上市发行安排及初步询价公告，本次发行拟发行 数量4010万股，拟募集资金39.04亿元，初步询价日2025年12月2日，申购日2025年12月5日。公开资料 显示，算丰信息是亿都国际的全资子公司，也是国产AI芯片明星公司沐曦的核心客户和股东。 ...

智通财经APP获悉，亿都(国际控股)(00259)盘中涨超10%，截至发稿，涨8.33%，报4.03港元，成交额 522.62万港元。 消息面上，沐曦股份发布首次公开发行股票并在科创板上市发行安排及初步询价公告，本次发行拟发行 数量4010万股，拟募集资金39.04亿元，初步询价日2025年12月2日，申购日2025年12月5日。公开资料 显示，算丰信息是亿都国际的全资子公司，也是国产AI芯片明星公司沐曦的核心客户和股东。 此外，亿都(国际控股)近期公布9月底中期业绩，收入约5.54亿港元，同比增长5.13%；公司拥有人应占 溢利约12.18亿港元，同比增长约11.55倍。溢利增加主要是由于按公允值计入损益的财务资产公允值变 动的收益所致。 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 億都(國際控股)有限公司 呈交日期: 2025年12月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00259 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.2 | HKD | | 400,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.2 | HKD | | 400,000,000 | 本月底法定/ ...

Group 1 - The company, Yidu (International Holdings) (00259), has granted stock options to four qualified participants, allowing them to subscribe to a total of 12.243 million ordinary shares with a par value of HKD 0.20 each [1] - The exercise price for the stock options is set at HKD 3.816 per share [1]

Core Viewpoint - The company, Yidu (International Holdings) (00259.HK), announced the granting of stock options to four qualified participants as part of a stock option plan adopted by shareholders, aimed at rewarding contributions to the group's ongoing operations and development [1] Group 1 - The stock option plan was approved by shareholders on August 16, 2024 [1] - A total of 12.24 million ordinary shares, each with a par value of HKD 0.20, have been granted under this plan [1] - The options are contingent upon acceptance by the participants [1]

Core Viewpoint - The company, Yidu (International Holdings) (00259), has granted stock options to four qualified participants, allowing them to subscribe to a total of 12.243 million ordinary shares at a nominal value of HKD 0.20 per share, with an exercise price of HKD 3.816 per share [1] Summary by Categories - **Stock Options Granted** - The company has issued stock options for a total of 12.243 million ordinary shares [1] - The nominal value of each share is HKD 0.20 [1] - The exercise price for the stock options is set at HKD 3.816 per share [1] - **Participants** - The stock options were granted to four qualified participants [1] - **Timeline** - The options were granted on November 21, 2025 [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 YEEBO (INTERNATIONAL HOLDINGS) LIMITED 億都（國際控股）有限公司 （於百慕達註冊成立之有限公司） （股份代號：259） 授出購股權 本公佈乃根據香港聯合交易所有限公司（「聯交所」）證券上市規則（「上市規則」） 第17.06A條發出。 億都（國際控股）有限公司（「本公司」，連同其附屬公司統稱「本集團」）董事（「董 事」）會（「董事會」）宣佈，於二零二五年十一月二十一日，根據本公司股東於二零 二四年八月十六日通過決議案採納的購股權計劃（「購股權計劃」），本公司已向四 名合資格參與者（「承授人」）授出附帶權利可認購本公司股本中合共12,243,000股 每股面值0.20港元的普通股（「股份」）的購股權（「購股權」），惟須獲承授人接納， 以獎勵承授人對本集團持續經營及發展所作出的貢獻。 已授出購股權的詳情如下： 授出日期： 二零二五年十一月二十一日 所授出購股權的行使價： ...

Group 1: Company Developments - Xinda Biologics announced that its dual receptor agonist, Masitide, achieved primary and all key secondary endpoints in Phase III clinical trials for obesity in China, showing a significant weight reduction of 20.08% compared to placebo in subjects with a BMI ≥30 [1] - Xinda Biologics plans to submit a marketing application for Masitide 9mg for adult weight management to the National Medical Products Administration [1] - RoboSense has secured a three-year exclusive partnership with FAW Toyota for a new electric vehicle model, marking the first Chinese tech company to enter Toyota's lidar supply chain [6] Group 2: Market Trends - The U.S. stock market experienced significant declines, with the Dow Jones down 386.51 points (0.84%), S&P 500 down 103.4 points (1.56%), and Nasdaq down 486.18 points (2.15%) [2] - The U.S. non-farm payrolls added 119,000 jobs in September, exceeding expectations of 50,000, indicating a shift in economic data and Federal Reserve stance [2] - The domestic smartphone market in China saw a shipment of 27.93 million units in September 2025, a year-on-year increase of 10.1%, with 5G phones accounting for 86.3% of total shipments [4] Group 3: Financial Performance - Luxshare Precision Holdings expects a mid-term profit increase of approximately 40% to 50% for the six months ending September 30, 2025, driven by effective product differentiation and sales strategies [13] - Yidu International Holdings reported a net profit of approximately HKD 1.218 billion for the six months ending September 30, 2025, reflecting an increase of about 1155% year-on-year [14] - NetEase reported a third-quarter net profit of approximately RMB 8.616 billion (USD 1.2 billion), a year-on-year increase of 31.77% [15][16]

Group 1 - The company reported a consolidated revenue of HKD 554 million for the six months ending September 30, 2025, representing a 5.1% increase from HKD 527 million in the same period last year [1] - Revenue from the sale of LCDs remained stable at approximately HKD 88.1 million, while revenue from LCMs and CTPs increased to HKD 182 million and HKD 183 million, respectively, compared to HKD 178 million and HKD 127 million in the previous year [1] - The profit attributable to the company's owners surged from HKD 97.1 million in the first half of 2024 to approximately HKD 1.218 billion, a significant increase of about HKD 1.121 billion, primarily due to gains from fair value changes of financial assets [1] Group 2 - The company is focused on developing products that meet market demand while expanding its customer base to ensure sustained sales growth [2] - The sales contribution from CTPs increased from 24.1% in the first half of 2024 to 32.9% in the current period, reflecting the growing demand for CTP applications [2] - The company is actively expanding its AI computing power and related business, which has significant long-term potential, although current revenue contributions are still minimal [2]

Core Insights - The company reported a revenue of approximately HKD 554 million for the six months ending September 30, 2025, representing a year-on-year growth of 5.13% [1] - Gross profit was approximately HKD 64.6 million, showing a year-on-year decrease of 21.2% [1] - Profit attributable to shareholders was approximately HKD 1.218 billion, reflecting a year-on-year increase of about 1155% [1] - Basic earnings per share were HKD 1.313 [1] Revenue and Profit Analysis - Revenue increased to HKD 554 million, up 5.13% compared to the previous year [1] - Gross profit decreased to HKD 64.6 million, down 21.2% year-on-year, primarily due to high fixed costs associated with the early development phase of AI computing power and related businesses [1] - The significant increase in profit attributable to shareholders was mainly driven by gains from the fair value changes of financial assets recognized in profit or loss [1]